Across 29,132 surgically treated T1 cases, lymph node metastasis hit 19.2% under age 50 vs 11.1% at 50 and older.
|Articles|March 15, 2019
The American Journal of Managed Care
- March 2019
- Volume 25
- Issue 3
Incorrect and Missing Author Initials in Affiliations and Authorship Information
Correction to the Trends From the Field article, “Risk Stratification for Return Emergency Department Visits Among High-Risk Patients,” published in the August 2017 issue of The American Journal of Managed Care®.
Advertisement
Am J Manag Care. 2019;25(3):140In the Trends From the Field article, “Risk Stratification for Return Emergency Department Visits Among High-Risk Patients,” published in the August 2017 issue of The American Journal of Managed Care®, an author’s initials were incorrect in the Author Affiliations and Authorship Information sections. The initials for Wei Duan-Porter, MD, PhD, should have been “WD-P.”
Additionally, the initials of another author were inadvertently omitted from the Author Affiliations section. The affiliation of Chad Kessler, MD, should have read “Ambulatory Care Service, Durham VA Medical Center (CK), Durham, NC.”
Articles in this issue
over 7 years ago
From the Editorial Board: Austin Frakt, PhDover 7 years ago
Did Medicaid Expansion Matter in States With Generous Medicaid?Advertisement
Related to this article
Medicare's cell and gene therapy payment gap remains, with hospitals absorbing costs as insurers limit coverage.
Congress's Mental Health TALK SAFE Act could expand telepsychiatry access by establishing permanent telehealth prescribing and licensing rules.
CDC data show cancer deaths declining as lung cancer treatment and detection advance, with new KRAS-targeted therapies showing early promise.
Nonadherence to semaglutide for obesity worsened once out-of-pocket costs passed roughly $75 per 30-day supply among commercially insured adults.
At a Stakeholder Interchange convened by The American Journal of Managed Care® in Houston, Texas, oncologists and pharmacists from academic and community practices debated how teclistamab- and talquetamab-based regimens stack up against CAR T-cell therapy in second-line multiple myeloma, and what it will take—staffing, caregiver support, hospital partnerships, and payer buy-in—to move step-up dosing out of the hospital and into the clinic.
All 50 states have applied for CMS's GENEROUS Model, a Medicaid drug pricing program expected to save $64.3 billion over the next decade.
HYPERION trial data shows a 76% reduction in clinical worsening events among adults recently diagnosed with PAH.
Advertisement
Advertisement
Trending on AJMC
1
Lung Cancer Progress Drives Down US Cancer Death Rates
2
All 50 States Apply for CMS's GENEROUS Model, With $64.3B in Savings Projected
3
Panel Confronts the Practical Barriers to Bringing Bispecifics Into Community Myeloma Care
4
Semaglutide Adherence Falls Once Out-of-Pocket Costs Top $75 a Month
5